Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus)

Journal of Neuroimmunology

Volumn 86, Issue 1, 1998, Pages 30-45

  Laman, Jon D ^a,b   Van Meurs, Marjan ^a   Schellekens, Marc M ^a   De Boer, Mark ^c   Melchers, Bert ^a   Massacesi, Luca ^d   Lassmann, Hans ^e   Claassen, Eric ^b   'T Hart, Bert A ^f  

^a TNO   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c PanGenetics BV   (Netherlands)

^d UNIVERSITY OF FLORENCE   (Italy)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

CD40; CD80; CD86; Macrophages; Multiple sclerosis; Non human primates

Indexed keywords

ALPHA INTERFERON; B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GLYCOPROTEIN GP 39; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; HELPER CELL; HISTOPATHOLOGY; IMMUNOCYTOCHEMISTRY; MACROPHAGE; MALE; MARMOSET; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ACID PHOSPHATASE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, CD86; BRAIN; BRAIN CHEMISTRY; CALLITHRIX; CYTOKINES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR ANTIGENS; INTERFERON TYPE II; INTERFERON-ALPHA; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-2; INTERLEUKIN-4; MACROPHAGES; MALE; MEMBRANE GLYCOPROTEINS; MULTIPLE SCLEROSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032101732     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00024-1     Document Type: Article

References (70)

1. Alderson M.R., Armitage R.J., Tough T.W., Strockbine L., Fanslow W.C., Spriggs M.K. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178:1993;669-674.
2. Arima T., Rehman A., Hickey W.F., Flye M.W. Inhibition by CTLA-4Ig of experimental allergic encephalomyelitis. J. Immunol. 156:1996;4916-4924.
3. Bagasra O., Michaels F.H., Zheng Y.M., Bobroski L.E., Spitsin S.V., Fu Z.F., Tawadros R., Koprowski H. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 92:1995;12041-12045.
4. Balashov K.E., Smith D.R., Khoury S.J., Hafler D.A., Weiner H.L. Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand. Proc. Natl. Acad. Sci. U.S.A. 94:1997;599-603.
5. Brosnan C.F., Cannella B., Battistini L., Raine C.S. Cytokine localization in multiple sclerosis lesions. Correlation with adhesion molecule expression and reactive nitrogen species. Neurol. 45:1995;16-21. Suppl. 6.
6. Brück W., Porada P., Poser S., Rieckmann P., Hanefeld F., Kretzschmar H.A., Lassmann H. Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann. Neurol. 38:1995;788-796.
7. Campbell K., Ovendale P.J., Kennedy M.K., Fanslow W.C., Reed S.G., Maliszewski C.R. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity. 4:1996;283-289.
8. Cannella B., Raine C.S. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 37:1995;425-435.
9. Claassen, E., Jeurissen, S.H.M. (in press). A step by step guide to in situ immune response analysis of lymphoid tissues by immunohistochemical methods. In: Weir, D.M., Blackwell, C., Herzenberg, L., Herzenberg, L. (Eds.), Handbook of Experimental Immunology, 5th edn., Blackwell Scientific Publications.
10. Cross A.H., Girard T.J., Giacoletto K.S., Evans R.J., Keeling R.M., Lin R.F., Trotter J.L., Karr R.W. Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation. J. Clin. Invest. 95:1995;2783-2789.
11. Desai-Mehta A., Lu L., Ramsey-Goldman R., Datta S.K. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J. Clin. Invest. 97:1996;2063-2073.
12. Durie F.H., Fava R.A., Foy T.M., Aruffo A., Ledbetter J.A., Noelle R.J. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Sci. 261:1993;1328-1330.
13. Foy T.M., Page D.M., Waldschmidt T.J., Schoneveld A., Laman J.D., Masters S.R., Tygrett L., Ledbetter J.A., Aruffo A., Claassen E., Xu J.C., Flavell R.A., Ohen S., Hedrick S.M., Noelle R.J. An essential role for gp39, the ligand for CD40, in thymic selection. J. Exp. Med. 182:1995;1377-1388.
14. Genain C.P., Lee-Parritz D., Nguyen M.-H., Massacesi L., Joshi N., Ferrante R., Hoffman K., Moseley M., Letvin N.L., Hauser S.L. In healthy primates, circulating autoreactive T cells mediate autoimmune disease. J. Clin. Invest. 94:1994;1339-1345.
15. Genain C.P., Nguyen M.-H., Letvin N.L., Pearl R., Davis R.L., Adelman M., Lees M.B., Linington C., Hauser S.L. Antibody facilitation of multiple sclerosis-like lesions in a non-human primate. J. Clin. Invest. 96:1995;2966-2974.
16. Genain C.P., Abel K., Belmar N., Villinger F., Rosenberg D.P., Linington C., Raine C.S., Hauser S.L. Late complications of immune deviation therapy in a nonhuman primate. Sci. 247:1996;2054-2057.
17. Gerritse K., Laman J.D., Noelle R.J., Aruffo A., Ledbetter J.A., Boersma W.J.A., Claassen E. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 93:1996;2499-2504.
18. Grewal I.S., Xu J., Flavell R.A. Impairment of antigen-specific T cell priming in mice lacking CD40 ligand. Nature. 378:1995;617-620.
19. Grewal I.S., Foellmer H.G., Grewal K.D., Xu J., Hardardottir F., Baron J.L., Janeway C.A., Flavell R.A. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Sci. 273:1996;1864-1867.
20. Grewal I.S., Flavell R.A. A central role of CD40 ligand in the regulation of CD4+ T cell responses. Immunol. Today. 17:1996;410-414.
21. Hoefakker S., Boersma W.J.A., Claassen E. Detection of human cytokines in situ using antibody and probe based methods. J. Immunol. Meth. 185:1995;149-175.
22. Hollenbaugh D., Mischel-Petty N., Edwards C.P., Simon J.C., Denfeld R.W., Kiener P.A., Aruffo A. Expression of functional CD40 by vascular endothelial cells. J. Exp. Med. 182:1995;33-40.
23. Huitinga I., Ruuls S.R., Jung S., Van Rooijen N., Hartung H.-P., Dijkstra C.D. Macrophages in T cell line mediated, demyelination and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats. Clin. Exp. Immunol. 100:1995;344-351.
24. Jaiswal A.I., Dubey C., Swain S.L., Croft M. Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not co-stimulatory signals. Int. Immunol. 8:1996;275-285.
25. Kamanaka M., Yu P., Yasui T., Yoshida K., Kawabe T., Horii T., Kishimoto T., Kikutani H. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity. 4:1996;275-281.
26. Karmann K., Hughes C.C., Schechner J., Fanslow W.C., Pober J.S. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc. Natl. Acad. Sci. U.S.A. 92:1995;4342-4346.
27. Kato T., Hakamada R., Yamane H., Nariuchi H. Induction of IL-12 p40 messenger RNA expression and IL-12 production of macrophages via CD40-CD40 ligand interaction. J. Immunol. 156:1996;3932-3938.
28. Kennedy M.K., Picha K.S., Fanslow W.C., Grabstein K.H., Alderson M.R., Clifford K.N., Chin W.A., Mohler K.M. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur. J. Immunol. 26:1996;370-378.
29. Khoury S.J., Akalin E., Chandraker A., Turka L.A., Linsley P.S., Sayegh M.H., Hancock W.W. CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. J. Immunol. 155:1995;4521-4524.
30. Kiener P.A., Moran-Davis P., Rankin B.M., Wahl A.F., Aruffo A., Hollenbaugh D. Stimulation of CD40 with purified soluble gp39 induces pro-inflammatory responses in human monocytes. J. Immunol. 155:1995;4917-4925.
31. Kojima K., Berger Th., Lassmann H., Hinze-Selch D., Zhan Y., Lu H., Lassmann H., Wekerle H. Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T-lymphocytes specific for the S-100β molecule, a calcium-binding protein of astroglia. J. Exp. Med. 180:1993;817-829.
32. Koshy M., Berger D., Crow M.K. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J. Clin. Invest. 98:1996;826-837.
33. Kuchroo V.K., Prabhu Das M., Brown J.A., Ranger A.M., Zamvil S.S., Sobel R.A., Weiner H.L., Nabavi N., Glimcher L.H. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell. 80:1995;707-718.
34. Kwekkeboom J., De Boer M., Mevissen M.L.C.M., Tager J.M., De Groot C. Signalling via CD40 plays an essential role in the activation of human B cells by murine EL4B5 cells. Immunol. 79:1993;439-445.
35. Laman J.D., Claassen E., Noelle R.J. Functions of CD40 and its ligand, gp39. Crit. Rev. Immunol. 16:1996;59-108.
36. Laman J.D., De Smet B.J.L.G., Schoneveld A., van Meurs M. CD4-CD4L interactions in atherosclerosis. Immunol. Today. 18:1997;272-277.
37. Lassmann, H. (in press) Multiple sclerosis pathology. In: McAlpine's Multiple Sclerosis, 3rd edn.
38. Lassmann, H., 1983. Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis. Neurology series, Vol. 25. Springer, Berlin.
39. Linington C., Lassmann H. Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with the antibody titre to the myelin/oligodendrocyte glycoprotein (MOG). J. Neuroimmunol. 17:1987;61-69.
40. Linington C., Engelhardt B., Kapocs G., Lassmann H. Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody. J. Neuroimmunol. 40:1992;219-224.
41. Liles W.C., Van Voorhis W.C. Nomenclature and biologic significance of cytokines involved in inflammation and the host immune response. J. Inf. Dis. 172:1995;1573-1580.
42. Marburg O. Die sogenannte "akute Multiple Sklerose" Jahrb. Psychiatrie. 27:1906;211-312.
43. Massacesi L., Genain C.P., Lee-Parritz D., Letvin N.L., Canfield D., Hauser S.L. Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis. Ann. Neurol. 37:1995;519-530.
44. McFarland H.F. Significance of autoreactive T cells in diseases such as multiple sclerosis using an innovative primate model. J. Clin. Invest. 94:1994;921-922.
45. McFarland H.F. The multiple sclerosis lesion. Ann. Neurol. 37:1995;419-421.
46. McFarland H.F. Complexities in the treatment of autoimmune disease. Sci. 247:1996;2037-2038.
47. Miller, S.D., Vanderlugt, C.L., Lenschow, D.J., Pope, J.G., Karandikar, N.J., Dal Canto, M.D., Bluestone, J.A., 1995. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity, 739-745.
48. Mohan C., Shi Y., Laman J.D., Datta S.K. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J. Immunol. 154:1995;1470-1480.
49. Olsson T. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 144:1995;245-268.
50. Peng X., Kasran A., Warmerdam P.A.M., De Boer M., Ceuppens J.L. Accessory signaling by CD40 for T cell activation: induction of Th1 and Th2 cytokines and synergy with interleukin-12 for interferon-γ production. Eur. J. Immmunol. 26:1996;1621-1627.
51. Perrin P.J., Scott D., Quigley L., Albert P.S., Feder O., Gray G.S., Abe R., June C.H., Racke M.K. Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. J. Immunol. 154:1995;1481-1490.
52. Racke M.K., Scott D.E., Quigley L., Gray G.S., Abe R., June C.H., Perrin P.J. Distinct roles for B7-1 (CD80) and B7-2 (CD86) in the initiation of experimental allergic encephalomyelitis. J. Clin. Invest. 96:1995;2195-2203.
53. Roy M., Aruffo A., Ledbetter J.A., Linsley P., Kehry M., Noelle R.J. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Eur. J. Immunol. 25:1995;596-603.
54. Shu U., Kiniwa M., Wu C.Y., Maliszewski C., Vezzio N., Hakimi J., Gately M., Delespesse G. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur. J. Immunol. 25:1995;1125-1128.
55. Soong L., Xu J.-C., Grewal I.S., Kima P., Sun J., Longley B.J., Ruddle N.H., McMahon-Pratt D., Flavell R.A. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity. 4:1996;263-273.
56. Stout R.D., Suttles J., Xu J., Grewal I.S., Flavell R.A. Impaired T cell macrophage activation in CD40 ligand-deficient mice. J. Immunol. 156:1996;8-11.
57. Stuber E., Strober W., Neurath M. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J. Exp. Med. 183:1996;693-698.
58. Swanborg R.H. Animal models of human disease: Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease. Clin. Immunol. Immunopathol. 77:1995;4-13.
59. Tian L., Noelle R.J., Lawrence D.A. Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1. Eur. J. Immunol. 25:1995;306-309.
60. Van Essen D., Kikutani H., Gray D. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature. 378:1995;620-623.
61. Van Kooten C., Banchereau J. CD40-CD40 ligand, a multifunctional receptor-ligand pair. Adv. Immunol. 61:1996;1-77.
62. Van Noort J.M., El Ouagmiri M., Boon J., Van Sechel A.C. Fractionation of central nervous system myelin proteins by reversed phase high-performance liquid chromatography. J. Chromatogr. 653:1994;155-161.
63. Van Noort J.M., Van Sechel A.C., Bajramovic J.A., El Ouagmiri M., Polman C.H., Lassmann H., Ravid R. The small heat-shock protein alphaB-crystallin as candidate autoantigen in multiple sclerosis. Nature. 375:1995;798-801.
64. Wagner D.H., Stout R.D., Suttles J. Role of the CD40-CD40 ligand interaction in CD4+ T cell contact-dependent activation of monocyte interleukin-1 synthesis. Eur. J. Immunol. 24:1994;3148-3154.
65. Wiley J.A., Harmsen A.G. CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice. J. Immunol. 155:1995;3525-3529.
66. Windhagen A., Newcombe J., Dangond F., Strand C., Woodroofe M.N., Cuzner M.L., Hafler D.A. Expression of costimulatory molecules B7-1 (CD80), B7-1 (CD86) and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 182:1995;1985-1996.
67. Woodroofe M.N. Cytokine production in the central nervous system. Neurol. 45:1995;6-10. Suppl. 6.
68. Woodroofe M.N., Cuzner M.L. Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by nonradioactive in situ hybridization. Cytokine. 5:1993;583-588.
69. Wucherpfennig K.W., Strominger J.L. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 80:1995;695-705.
70. Yellin M.J., Sippel K., Inghirami G., Covey L.R., Lee J.J., Sinning J., Clark E.A., Chess L., Lederman S. CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L Potential role in regulating helper effector function. J. Immunol. 152:1994;598-608.